Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays.

about

Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays.

Item

http://www.wikidata.org/entity/Q47834734

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Determinants of high on-treatm ...... rifyNow and Multiplate assays.

@en

Determinants of high on-treatm ...... rifyNow and Multiplate assays.

@nl

type

Item

label

Determinants of high on-treatm ...... rifyNow and Multiplate assays.

@en

Determinants of high on-treatm ...... rifyNow and Multiplate assays.

@nl

prefLabel

Determinants of high on-treatm ...... rifyNow and Multiplate assays.

@en

Determinants of high on-treatm ...... rifyNow and Multiplate assays.

@nl

P1476

Determinants of high on-treatm ...... rifyNow and Multiplate assays.

@en

P2093

Agnieszka Graczyk-Szuster

http://www.w3.org/2001/XMLSchema#string

Aleksandra Tomczak

http://www.w3.org/2001/XMLSchema#string

Anna Komosa

http://www.w3.org/2001/XMLSchema#string

Franciszek Główka

http://www.w3.org/2001/XMLSchema#string

Maciej Lesiak

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data.

Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.

Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.

Mutational analysis clopidogrel resistance and platelet function in patients scheduled for coronary artery bypass grafting.

First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studies.

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis

P304

190-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365513.2017.1286686

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dorota Danielak

Marta Karaźniewicz-Łada

P577

2017-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28276728

http://www.w3.org/2001/XMLSchema#string